Alerts will be sent to your verified email
Verify EmailSTAR
Strides Pharma Scien
|
Wockhardt
|
Laxmi Organic Inds.
|
|
---|---|---|---|
Operational Metrics
|
|||
Pharmaceutical Sector
|
|||
Number of ANDA's Filed in USA
|
260.0 . | n/a | n/a |
Number of ANDA's Approved By USFDA
|
235.0 . | n/a | n/a |
R&D as a % of Total Sales
|
2.24 % | 4.4 % | n/a |
Financials
|
|||
5 yr Average ROE
|
-1.06 % | -3.81 % | 14.71 % |
5yr average Equity Multiplier
|
2.7 | 2.26 | 2.0 |
5yr Average Asset Turnover Ratio
|
0.45 | 0.39 | 1.29 |
5yr Avg Net Profit Margin
|
0.77 % | -4.46 % | 5.83 % |
Price to Book
|
4.07 | 3.85 | 4.0 |
P/E
|
0.0 | 0.0 | 59.6 |
5yr Avg Cash Conversion Cycle
|
-89.35 Days | -118.47 Days | 8.54 Days |
Inventory Days
|
71.49 Days | 68.12 Days | 37.92 Days |
Days Receivable
|
73.25 Days | 71.63 Days | 80.83 Days |
Days Payable
|
261.28 Days | 260.3 Days | 113.09 Days |
5yr Average Interest Coverage Ratio
|
0.64 | -0.67 | 10.34 |
5yr Avg ROCE
|
6.23 % | -1.45 % | 17.71 % |
5yr Avg Operating Profit Margin
|
14.43 % | 6.14 % | 10.53 % |
5 yr average Debt to Equity
|
1.04 | 0.71 | 0.26 |
5yr CAGR Net Profit
|
n/a | 46.24 % | 11.47 % |
5yr Average Return on Assets
|
-0.26 % | -1.84 % | 7.44 % |
Shareholdings
|
|||
Promoter Holding
|
25.88 % | 51.6 % | 69.72 % |
Share Pledged by Promoters
|
72.7 % | 52.9 % | 0.0 |
Change in Promoter Holding (3 Yrs)
|
-3.79 % | -20.52 % | -3.2 % |
Change in Mutual Fund Holding (3 Yrs)
|
-4.24 % | 3.1 % | 0.22 % |
Strides Pharma Scien
|
Wockhardt
|
Laxmi Organic Inds.
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
-
|
Operating Profit Break-Up
|
Customer Segment
|
Customer Segment
|
-
|
-
|
Asset Break-Up - Segment Wise
|
Asset Break-Up - Segment Wise
|
-
|
-
|
Asset Break-Up
|
Asset Break-Up
|
Asset Break-Up
|
-
|